The rising price issues will pose the greatest hindrance to the medical cannabis industry in the coming weeks. CEO of Lio Pharmaceuticals and German distributor Alain Menghé à Menghé does not believe these recent hostilities won’t impact the entire industry. Menghé is currently building a manufacturing plant in Solingen, Dusseldorf.
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of…
Based on the ruling, products that are legal federally as well as at the state…
The drug’s history of healing and experimentation stretches from ancient China to American counterculture —…
The new partnership will spotlight the stories of people still behind bars for cannabis, support…
Colombia is moving forward with a controversial plan to euthanize dozens of invasive hippos descended…
Imported hashish sustained mountain economies for centuries—until modern legalization and market economics erased it almost…